✦ LIBER ✦

Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial

✍ Scribed by Marc LÉmann; Jean–Yves Mary; Bernard Duclos; Michel Veyrac; Jean–Louis Dupas; Jean Charles Delchier; David Laharie; Jacques Moreau; Guillaume Cadiot; Laurence Picon; Arnaud Bourreille; Iradj Sobahni; Jean–Frederic Colombel

Book ID: 119759144
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 251 KB
Volume: 130
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2006.02.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P210 Azathioprine versus azathioprine pl

P210 Azathioprine versus azathioprine plus metronidazole for the prevention of postoperative endoscopic recurrence of Crohn's disease: A randomized, placebo-controlled trial

✍ M. Mañosa; E. Cabré; I. Bernal; M. Esteve; E. Garcia Planella; E. Ricart Gómez; 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 51 KB

P087 - SONIC: a randomized, double-blind

P087 - SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy

✍ J.F. Colombel; P. Rutgeerts; W. Reinisch; G.J. Mantzaris; A. Kornbluth; D. Rachm 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 63 KB

Etanercept for Active Crohn's Disease: A

Etanercept for Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ William J. Sandborn; Stephen B. Hanauer; Seymour Katz; Michael Safdi; Douglas G. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 181 KB

921 Long Term Follow-Up of a Cohort of S

921 Long Term Follow-Up of a Cohort of Steroid-Dependent Crohn's Disease Patients Included in a Randomized Trial Evaluating Short Term Infliximab Combined with Azathioprine

✍ Laurent Costes; Jean-Frédéric Colombel; Jean-Yves Mary; Bernard Duclos; Michel V 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 173 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

P010 LONG TERM FOLLOW-UP OF A COHORT OF

P010 LONG TERM FOLLOW-UP OF A COHORT OF STEROID-DEPENDENT CROHN'S DISEASE PATIENTS INCLUDED IN A RANDOMIZED TRIAL EVALUATING SHORT TERM INFLIXIMAB COMBINED WITH AZATHIOPRINE

✍ L. Costes; J.F. Colombel; J. Mary; B. Duclos; M. Veyrac; J. Dupas; J. Delchier; 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 70 KB